Presenting at ITCC in Vienna by our PhD student Dr Julie Messiaen

Innovative Therapies for Children with Cancer: ITCC Conference for the first time in Vienna

Our PhD student Dr Julie Messiaen had the opportunity to present her research work on pediatric brain tumors, at the first conference of the consortium for “Innovative Therapies for Children with Cancer in Europe.
On May 25th, the first two-day conference of the consortium for “Innovative Therapies for Children with Cancer in Europe” (ITCC) was held in Vienna. St. Anna Children’s Cancer Research Institute, St. Anna Children’s Hospital, and the Pediatric Neuro-Oncology Department of the Medical University of Vienna welcomed scientists from all over Europe and the USA. The common goal: Improving the treatment of pediatric cancer in the future.
Malignant diseases such as cancer continue to be one of the leading causes of death among children and adolescents. The Consortium for “Innovative Therapies for Children with Cancer in Europe” (ITCC) is one of the largest collaborative groups in the field of pediatric oncology, driving the development of new therapies for the treatment of cancer in children and adolescents.